Placebo to match LY3556050
J2P-MC-LXBD
Phase 2 small_molecule active
Quick answer
Placebo to match LY3556050 for Diabetic Peripheral Neuropathy is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Diabetic Peripheral Neuropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active